Afghanistan 2022 Ban Impact: Following the April 2022 Taliban decree, Afghan production plummeted from 6,200 tons baseline down to ~330 tons in 2025 (-95%). Supply inelasticity pushed global buyers toward Southeast Asia, triggering a surge in Myanmar to over 1,000 tons, along with a +42% spike in synthetic opioid market penetration.